Objectives: Elevated homocysteine (Hcy) concentrations have been shown to be a risk factor for atherosclerotic vascular disease and thrombosis. Increased asymmetric dimethylarginine (ADMA) levels have been implicated in the pathogenesis of numerous conditions affecting the cardiovascular system. In this study, the influence of cardiovascular risk factors and other variables on Hcy and ADMA relationship in patients with coronary artery disease (CAD) was investigated
BACKGROUND/AIMS: Coronary artery disease (CAD) is a major cause of mortality worldwide. Hyperhomocys...
Item does not contain fulltextCardiovascular diseases (CVD), especially coronary heart disease (CHD)...
PubMedID: 12825803Most cross-sectional and case-control studies indicate that an increased plasma to...
Objectives: Elevated homocysteine (Hcy) concentrations have been shown to be a risk factor for ather...
Background: CAD is the leading cause of death. Many factors are responsible for causing CAD, but 5 t...
Objective: Coronary artery disease is major cause of mortality and morbidity. Homocysteine has long ...
Item does not contain fulltextBACKGROUND: Coronary artery disease (CAD) still represents the major c...
Purpose: It is unclear whether plasma homocysteine (Hcy) has a direct noxious impact on the cardiova...
To establish whether the frequent finding of a moderate–intermediate increase in plasma total homocy...
Background: Hyperhomocysteinemia is one of the newly recognised risk factors of coronary artery dise...
BACKGROUND: Asymmetric dimethylarginine (ADMA) plasma levels have been shown to be elevated in disea...
BACKGROUND: Coronary artery disease (CAD) still represents the major cause of mortality in develope...
Background: Elevated levels of total plasma homocysteine are a risk factor for atherosclerotic disea...
Background: Globally, cardiovascular diseases (CVD), including myocardial infarction (MI) and stroke...
Elevated total plasma homocysteine (tHcy) levels constitute a risk factor for coronary artery diseas...
BACKGROUND/AIMS: Coronary artery disease (CAD) is a major cause of mortality worldwide. Hyperhomocys...
Item does not contain fulltextCardiovascular diseases (CVD), especially coronary heart disease (CHD)...
PubMedID: 12825803Most cross-sectional and case-control studies indicate that an increased plasma to...
Objectives: Elevated homocysteine (Hcy) concentrations have been shown to be a risk factor for ather...
Background: CAD is the leading cause of death. Many factors are responsible for causing CAD, but 5 t...
Objective: Coronary artery disease is major cause of mortality and morbidity. Homocysteine has long ...
Item does not contain fulltextBACKGROUND: Coronary artery disease (CAD) still represents the major c...
Purpose: It is unclear whether plasma homocysteine (Hcy) has a direct noxious impact on the cardiova...
To establish whether the frequent finding of a moderate–intermediate increase in plasma total homocy...
Background: Hyperhomocysteinemia is one of the newly recognised risk factors of coronary artery dise...
BACKGROUND: Asymmetric dimethylarginine (ADMA) plasma levels have been shown to be elevated in disea...
BACKGROUND: Coronary artery disease (CAD) still represents the major cause of mortality in develope...
Background: Elevated levels of total plasma homocysteine are a risk factor for atherosclerotic disea...
Background: Globally, cardiovascular diseases (CVD), including myocardial infarction (MI) and stroke...
Elevated total plasma homocysteine (tHcy) levels constitute a risk factor for coronary artery diseas...
BACKGROUND/AIMS: Coronary artery disease (CAD) is a major cause of mortality worldwide. Hyperhomocys...
Item does not contain fulltextCardiovascular diseases (CVD), especially coronary heart disease (CHD)...
PubMedID: 12825803Most cross-sectional and case-control studies indicate that an increased plasma to...